Y-27632 dihydrochloride 是一种 ATP 竞争性的 ROCK 抑制剂，具有口服活性。Y-27632 dihydrochloride (GMP) 具有抗癫痫作用，可用于细胞研究生产的辅助试剂。

Fasudil HCl (HA-1077; AT877)是一种非特异性RhoA/ROCK抑制剂，同时抑制蛋白激酶，对ROCK1的Ki为0.33 μM，对ROCK2、PKA、PKC和PKG的IC50值分别为0.158 μM、4.58 μM、12.30 μM和1.650 μM。Fasudil盐酸盐还是一种强效的Ca2+通道拮抗剂和血管扩张剂。

GSK429286A selectively inhibits ROCK1 and ROCK2 with the IC50 value of 14 nM and 63 nM, respectively.

RKI-1447 is a potent small molecule inhibitor of ROCK1 and ROCK2, with IC50 of 14.5 nM and 6.2 nM, respectively, and has anti-invasive and antitumor activities.

H-1152 2HCl, an isoquinolinesulfonamide derivative, is a more specific, stronger and membrane-permeable inhibitor of Rho-kinase with a Ki value of 1.6 nM, but poor inhibitor of other serine/threonine kinases.

ROCK inhibitor is a highly potent inhibitor of human ROCK-1 and ROCK-2 isoenzymes with IC50 values of 0.6 and 1.1 nM, respectively.

GSK269962 HCl is a selective ROCK (Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.

K-115 HCl is potent ROCK inhibitor with IC50 of 51 nM and 19 nM for ROCK1 and ROCK2, respectively, used for the treatment of glaucoma and ocular hypertension.

Belumosudil (KD025) 是一种选择性 ROCK2 抑制剂，对 ROCK2 的 IC50 值为 105 nM，对 ROCK1 的 IC50 值为 24 µM，具有抗纤维化特性。

Chroman 1 is a highly potent and selective ROCK II inhibitor.

Hydroxyfasudil HCl, metabolite of fasudil, is a potent Rho-kinase inhibitor and vasodilator.

AT13148 is an oral, ATP-competitive, multi-AGC kinase inhibitor with IC50 of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively.